share_log

Needham Reiterates Buy on Collegium Pharmaceutical, Maintains $40 Price Target

Moomoo 24/7 ·  Apr 11 05:58

Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $40 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment